<DOC>
	<DOCNO>NCT02707523</DOCNO>
	<brief_summary>The propose study randomize , double mask , placebo-controlled pilot trial azithromycin treatment child RSV-induced respiratory failure .</brief_summary>
	<brief_title>Prospective Pilot Clinical Trial Azithromycin Treatment In RSV-Induced ( Respiratory Syncytial Virus - Induced ) Respiratory Failure In Children</brief_title>
	<detailed_description>Study participant enrol Pediatric Intensive Care Unit ( PICU ) Children 's Alabama . Samples collect analyzed PI 's lab University Alabama Birmingham . Drug pharmacokinetics perform Pharmaceutical Sciences Research Institute Samford University , Birmingham , AL .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>Admission PICU RSV infection mechanical ventilation Randomization drug/placebo initiation within 48 hour mechanical ventilation Age le 2 year Azithromycin use within 7 day PICU admission Contraindication azithromycin use include : Patients electrocardiogram QT interval correct heart rate ( Qtc ) â‰¥ 450 m Patients significant hepatic impairment ( direct bilirubin &gt; 1.5 mg/dL ) Known hypersensitivity azithromycin , erythromycin , macrolide , ketolide drug Cardiac arrhythmia History pyloric stenosis Immunocompromised child ( cause ) Current use medication know cause QT prolongation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>RSV</keyword>
	<keyword>respiratory support</keyword>
	<keyword>RSV induce respiratory failure</keyword>
</DOC>